- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetics in NAFLD/NASH: Targets and therapy
Authors
Keywords
HDAC, Non-alcoholic fatty liver disease, Non-alcoholic steatohepatitis, DNA methylation, Histone modification, MicroRNAs
Journal
PHARMACOLOGICAL RESEARCH
Volume 167, Issue -, Pages 105484
Publisher
Elsevier BV
Online
2021-03-24
DOI
10.1016/j.phrs.2021.105484
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paternal Methyl Donor Supplementation in Rats Improves Fertility, Physiological Outcomes, Gut Microbial Signatures and Epigenetic Markers Altered by High Fat/High Sucrose Diet
- (2021) Faye Chleilat et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigenetic Regulation of Adipogenesis in Development of Metabolic Syndrome
- (2021) Richa Pant et al. Frontiers in Cell and Developmental Biology
- Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice
- (2020) Jin Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Epigenetics of the Endocannabinoid System
- (2020) Meccariello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Astaxanthin attenuates hepatic damages and mitochondrial dysfunction in nonalcoholic fatty liver disease by up‐regulating the FGF21/PGC‐1α pathway
- (2020) Liwei Wu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Potential Adverse Effects of Resveratrol: A Literature Review
- (2020) Abdullah Shaito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Geniposide alleviates non‐alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways
- (2020) Bingyu Shen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease
- (2020) Ali Bayoumi et al. TRENDS IN GENETICS
- MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury
- (2020) Jovana Markovic et al. Cells
- Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review
- (2020) Ashwani S. Patil et al. BIOMEDICINE & PHARMACOTHERAPY
- Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease
- (2019) Siti Aishah Sulaiman et al. Frontiers in Physiology
- Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
- (2019) Simona Marchisello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)
- (2019) Naim Alkhouri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing
- (2019) Ying Zhang et al. Annals of Hepatology
- Cyclophilin inhibition as a potential treatment for nonalcoholic steatohepatitis (NASH)
- (2019) Daren R. Ure et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway
- (2019) Hossein Hosseini et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease
- (2019) Jelena Stevanović et al. Molecular Metabolism
- Epigenetic effects of metformin: From molecular mechanisms to clinical implications
- (2018) Stephanie Claire Bridgeman et al. DIABETES OBESITY & METABOLISM
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease
- (2018) Donald B. Jump et al. PHARMACOLOGY & THERAPEUTICS
- Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway
- (2018) Qiang Ou et al. DIGESTIVE DISEASES AND SCIENCES
- Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist/ CB2R agonist aminoalkylindole derivatives in mice
- (2018) Sherrica Tai et al. DRUG AND ALCOHOL DEPENDENCE
- Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?
- (2018) Mark A. Febbraio et al. Cell Metabolism
- miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis
- (2018) Paola Dongiovanni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrative regulation of physiology by histone deacetylase 3
- (2018) Matthew J. Emmett et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs
- (2018) Barbara Capuani et al. Frontiers in Endocrinology
- Emerging roles of SIRT1 in fatty liver diseases
- (2017) Ren-Bo Ding et al. International Journal of Biological Sciences
- Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD
- (2017) J Latorre et al. INTERNATIONAL JOURNAL OF OBESITY
- Pleiotropic and Adverse Effects of Statins—Do Epigenetics Play a Role?
- (2017) Stephanie C. Allen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Therapies in non-alcoholic steatohepatitis (NASH)
- (2017) Abdul M. Oseini et al. LIVER INTERNATIONAL
- “Metformin-resistant” folic acid producing probiotics or folic acid against metformin’s adverse effects like diarrhea
- (2017) Abdullah Olgun MEDICAL HYPOTHESES
- Epigenetics in non-alcoholic fatty liver disease
- (2017) Jooho Lee et al. MOLECULAR ASPECTS OF MEDICINE
- Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
- (2017) Sukhpreet Singh et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
- (2017) Hironori Kitade et al. Nutrients
- Vitamin E Modifies High-Fat Diet-Induced Increase of DNA Strand Breaks, and Changes in Expression and DNA Methylation of Dnmt1 and MLH1 in C57BL/6J Male Mice
- (2017) Marlene Remely et al. Nutrients
- MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR)
- (2017) Xianchao An et al. MEDICAL SCIENCE MONITOR
- SIRT3: Oncogene and Tumor Suppressor in Cancer
- (2017) Margalida Torrens-Mas et al. Cancers
- Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease
- (2016) William N. Hannah et al. DIGESTIVE DISEASES AND SCIENCES
- Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
- (2016) Mei Xiang et al. JOURNAL OF HEPATOLOGY
- The role of sirtuins in cellular homeostasis
- (2016) Wioleta Kupis et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease
- (2016) Sabina Paglialunga et al. Lipids in Health and Disease
- Nonalcoholic steatohepatitis (NASH) drugs market
- (2016) Sorcha Cassidy et al. NATURE REVIEWS DRUG DISCOVERY
- Berberis Vulgarisand Berberine: An Update Review
- (2016) Mohsen Imenshahidi et al. PHYTOTHERAPY RESEARCH
- Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
- (2016) Amrita Ostawal et al. Diabetes Therapy
- Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
- (2016) Amrita Ostawal et al. Diabetes Therapy
- Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression
- (2015) Darkiane Fernandes Ferreira et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway
- (2015) Heng Wu et al. GUT
- Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease
- (2015) Chao Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Heterogeneous Ribonucleoprotein K (hnRNP K) Binds miR-122, a Mature Liver-Specific MicroRNA Required for Hepatitis C Virus Replication
- (2015) Baochang Fan et al. MOLECULAR & CELLULAR PROTEOMICS
- Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet
- (2015) Aline B. Santamarina et al. PLoS One
- Astaxanthin Normalizes Epigenetic Modifications of Bovine Somatic Cell Cloned Embryos and Decreases the Generation of Lipid Peroxidation
- (2015) R Li et al. REPRODUCTION IN DOMESTIC ANIMALS
- Circulating microRNAs in nonalcoholic fatty liver disease
- (2015) Johanna K. DiStefano et al. Expert Review of Gastroenterology & Hepatology
- Efecto de los ácidos grasos poliinsaturados en la prevención de la obesidad a través de modificaciones epigenéticas
- (2015) Julián F. Hernando Boigues et al. Endocrinologia y Nutricion
- Enzymatic DNA oxidation: mechanisms and biological significance
- (2014) Guo-Liang Xu et al. BMB Reports
- Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease
- (2014) Duarte M. S. Ferreira et al. FEBS Journal
- Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
- (2014) Carlos J Pirola et al. GUT
- Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia
- (2014) Raymond Ng et al. HEPATOLOGY
- Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity
- (2014) Gianluigi Mazzoccoli et al. LIVER INTERNATIONAL
- Chloroquine interferes with dengue-2 virus replication in U937 cells
- (2014) Kleber Juvenal Silva Farias et al. MICROBIOLOGY AND IMMUNOLOGY
- Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition
- (2014) Joo Lee et al. Nutrients
- The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review
- (2013) Zun Xiang et al. BMC GASTROENTEROLOGY
- Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease
- (2013) Yuhao Zhang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease
- (2013) Susan K. Murphy et al. GASTROENTEROLOGY
- Hepatic SIRT1 Attenuates Hepatic Steatosis and Controls Energy Balance in Mice by Inducing Fibroblast Growth Factor 21
- (2013) Yu Li et al. GASTROENTEROLOGY
- Dual Role of MicroRNAs in NAFLD
- (2013) Sara Ceccarelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
- (2013) Yasar Colak et al. MEDICAL SCIENCE MONITOR
- NAFLD in Asia—as common and important as in the West
- (2013) Geoffrey C. Farrell et al. Nature Reviews Gastroenterology & Hepatology
- Correction: Immunopositivity for Histone MacroH2A1 Isoforms Marks Steatosis-Associated Hepatocellular Carcinoma
- (2013) Francesca Rappa et al. PLoS One
- The potential of microRNAs in liver fibrosis
- (2012) Yong He et al. CELLULAR SIGNALLING
- Seven sirtuins for seven deadly diseases ofaging
- (2012) Brian J. Morris FREE RADICAL BIOLOGY AND MEDICINE
- Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease
- (2012) Carlos Jose Pirola et al. GUT
- MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis
- (2012) Tomohiro Ogawa et al. GUT
- Role of cytokines and chemokines in non-alcoholic fatty liver disease
- (2012) Vincent Braunersreuther WORLD JOURNAL OF GASTROENTEROLOGY
- High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis
- (2011) Jiyun Ahn et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- SIRT3 Deficiency and Mitochondrial Protein Hyperacetylation Accelerate the Development of the Metabolic Syndrome
- (2011) Matthew D. Hirschey et al. MOLECULAR CELL
- miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
- (2011) A. Davalos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study
- (2010) Lei Kong et al. ACTA DIABETOLOGICA
- Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice
- (2010) Julien Bricambert et al. JOURNAL OF CLINICAL INVESTIGATION
- SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells
- (2010) Tong SHI et al. Journal of Digestive Diseases
- Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis
- (2010) Quentin M. Anstee et al. JOURNAL OF HEPATOLOGY
- Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet
- (2010) Volodymyr P. Tryndyak et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice
- (2009) Yu Yamazaki et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
- (2009) K. E. Wellen et al. SCIENCE
- The carotenoid -cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells
- (2008) Y. Lorenzo et al. CARCINOGENESIS
- Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-κB-dependent Inflammatory Genes
- (2008) Yan Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now